NCT06373224

Brief Summary

Patients undergoing an endobronchial ultrasound and biopsy can experience bleeding during the biopsy. These biopsies are read in real time by pathologists who travel to the endoscopy unit during the procedure. Often, when this happens, the blood contaminates the pathology slides making the slide unreadable. This then requires more biopsies to be performed, thus prolonging the procedure, and increasing anesthesia time. One innovative way to reduce bleeding may be to irrigate the bronchial wall with cold saline, where the biopsy is to be taken, immediately before biopsy, thus causing vasoconstriction and possibly resulting in less blood contamination on the biopsy slides. The current study will evaluate this prophylactic irrigation with saline to control bleeding, thus resulting in a quicker diagnostic result of the biopsies.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Dec 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 3, 2023

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
5 months until next milestone

First Posted

Study publicly available on registry

April 18, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 23, 2025

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
3 months until next milestone

Results Posted

Study results publicly available

April 2, 2026

Completed
Last Updated

April 2, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

August 3, 2023

Results QC Date

February 12, 2026

Last Update Submit

March 13, 2026

Conditions

Keywords

Biopsy

Outcome Measures

Primary Outcomes (1)

  • Unreadable Biopsy Slides

    cumulative number of unreadable slides across all biopsy slides noted by the pathologist to be unreadable due to blood on slide

    from enrollment until discharge from biopsy appointment, up to 12 hours

Study Arms (2)

Flush Group

EXPERIMENTAL

After identifying the lymph node or lesion to be biopsied on ultrasound, using the endobronchial ultrasound scope, two 60mL syringes of cold saline will be inserted, through the biopsy channel of the endobronchial ultrasound scope, directly onto the bronchial wall where the biopsies are to be performed. The saline will then be sucked out of the airway using the endobronchial ultrasound scope.

Other: Flush

Standard Care Group

NO INTERVENTION

No irrigation before the biopsy

Interventions

FlushOTHER

After identifying the lymph node or lesion to be biopsied on ultrasound, using the endobronchial ultrasound scope, two 60mL syringes of cold saline will be inserted, through the biopsy channel of the endobronchial ultrasound scope, directly onto the bronchial wall where the biopsies are to be performed. The saline will then be sucked out of the airway using the endobronchial ultrasound scope.

Flush Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing an endobronchial ultrasound and biopsy at Bethesda North Hospital

You may not qualify if:

  • Under 18 years old
  • Does not speak English
  • Unable to consent to involvement in the research study
  • Is pregnant
  • Has a bleeding disorder/diagnosis
  • Currently taking anticoagulant medications and not stopped for procedure
  • Documented low platelets (\<100,000)
  • Had a biopsy taken immediately prior to the endobronchial ultrasound

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bethesda North Hospital

Cincinnati, Ohio, 45242, United States

Location

MeSH Terms

Conditions

Lung Diseases

Condition Hierarchy (Ancestors)

Respiratory Tract Diseases

Results Point of Contact

Title
Nurse Researcher
Organization
TriHealth

Study Officials

  • Austin Pittman, BSN, RN

    TriHealth Inc.

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 3, 2023

First Posted

April 18, 2024

Study Start

December 1, 2023

Primary Completion

May 23, 2025

Study Completion

December 30, 2025

Last Updated

April 2, 2026

Results First Posted

April 2, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations